951122-54-6 Usage
Uses
Used in Pharmaceutical Industry:
2-(Bromomethyl)-5-phenylbenzo[d]thiazole is used as a pharmaceutical agent for its potential anti-cancer properties. It has been studied for its ability to target and inhibit the growth of cancer cells, making it a promising candidate for the development of novel cancer therapies.
2-(Bromomethyl)-5-phenylbenzo[d]thiazole is also used as an anti-inflammatory agent, leveraging its potential to modulate inflammatory pathways and alleviate inflammation-related symptoms.
Used in Organic Synthesis:
2-(Bromomethyl)-5-phenylbenzo[d]thiazole serves as an intermediate in the production of other organic compounds. Its unique structure allows for further chemical modifications and the synthesis of new molecules with potential applications in various fields, including pharmaceuticals, materials science, and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 951122-54-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,1,1,2 and 2 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 951122-54:
(8*9)+(7*5)+(6*1)+(5*1)+(4*2)+(3*2)+(2*5)+(1*4)=146
146 % 10 = 6
So 951122-54-6 is a valid CAS Registry Number.
951122-54-6Relevant academic research and scientific papers
Creating an antibacterial with in vivo efficacy: Synthesis and characterization of potent inhibitors of the bacterial cell division protein FTSZ with improved pharmaceutical properties
Haydon, David J.,Bennett, James M.,Brown, David,Collins, Ian,Galbraith, Greta,Lancett, Paul,MacDonald, Rebecca,Stokes, Neil R.,Chauhan, Pramod K.,Sutariya, Jignesh K.,Nayal, Narendra,Srivastava, Anil,Beanland, Joy,Hall, Robin,Henstock, Vincent,Noula, Caterina,Rockley, Chris,Czaplewski, Lloyd
supporting information; experimental part, p. 3927 - 3936 (2010/09/04)
3-Methoxybenzamide (1) is a weak inhibitor of the essential bacterial cell division protein FtsZ. Alkyl derivatives of 1 are potent antistaphylococcal compounds with suboptimal drug-like properties. Exploration of the structure-activity relationships of analogues of these inhibitors led to the identification of potent antistaphylococcal compounds with improved pharmaceutical properties.
